Delivery Order SPE2DB22D3501-SPE2DB23FXA22

Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $55
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $38,950 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561950156, described as Docetaxel 80 mg/4 ml vials in 4 ml quantities. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania, with performance required between August 25-28, 2023. No additional details were provided on the original solicitation or any overarching contract vehicle. The funding agency, DLA, acts as the...
The Defense Logistics Agency awarded a $439,260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561288641, which is described as Docetaxel 160 MG/8 ML VIAL 8ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is short, spanning from June 20, 2023 to June 21, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency supports...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $54,620 under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is to provide 160 mg/8 ml vials of the chemotherapy drug docetaxel for the period of August 28-29, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency functions to support the resupply needs of the U.S. military...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $5,745 to Amerisourcebergen Drug Corporation for the supply of 4561666199 DOCETAXEL 160 MG/16 ML VIAL 16ML. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the United States...
The Defense Logistics Agency awarded a $64,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561339212 DOCETAXEL 160 MG/8 ML VIAL 8ML. As a prime contractor for pharmaceutical products, Amerisourcebergen will supply the anticancer medication docetaxel to the DLA, which manages the Department of Defense's global logistics operations. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from...
The Defense Logistics Agency awarded a $54,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561950154, which is described as docetaxel 160 mg/8 ml vials packaged in 8 ml quantities. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 25, 2023 through August 28, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $7,860 to Amerisourcebergen Drug Corporation for the supply of docetaxel, a chemotherapy drug. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August 2023. As one of the largest medical supply procurement agencies of the U.S. Department of Defense, the DLA supports America's armed forces by acquiring and delivering critical...
The Defense Logistics Agency awarded a $64,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561339219 DOCETAXEL 160 MG/8 ML VIAL 8ML pharmaceutical products. As the prime contractor, Amerisourcebergen will deliver the chemotherapy drugs from its Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified in the award information. The delivery order...
The Defense Logistics Agency awarded a $478,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 mg/16 ml vials of docetaxel. The single order is for an unspecified quantity of the chemotherapy drug to be delivered to a Conshohocken, Pennsylvania facility between July 14-17, 2023. Amerisourcebergen will serve as the prime contractor, with no mention of major subcontractors. The DLA manages the Department of Defense's global logistics operations,...
The Defense Logistics Agency awarded a $54,620 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 160 mg/8 ml vials of docetaxel. The single delivery order was issued under an existing prime vendor contract vehicle and requires Amerisourcebergen to deliver the chemotherapy drug to a facility in Conshohocken, Pennsylvania by July 25, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency manages the global supply...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB23FXA22
    Delivery Order

The Defense Logistics Agency awarded a $54,620 delivery order to Amerisourcebergen Drug Corporation for the supply of 4561950151, which is described as Docetaxel 160 MG/8 ML VIAL 8ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the specified pharmaceutical product to DLA from Amerisourcebergen's facility located in Conshohocken, Pennsylvania. Performance will take place between August 25-28, 2023. As the DLA supports the medical readiness of the Unites States armed forces, this order for an oncology drug will likely support treatment for military service members and their families.

Generated 12/22/23, 9:58 PM